Elsevier
  Sign Up Send Feedback Tell a Friend Search Archive View Sample
 
Weekly E-Mail newsletter
For physicians in Internal Medicine, Cardiology, Geriatrics, Women's Health,
and Adolescent Medicine
News from hundreds of top industry sources
It's what clinicians need to know
It's FREE!
   
  About SmartBrief

About The American Journal of Medicine, published by Elsevier

About Elsevier

Visit other Elsevier Health Science publications

Privacy Policy
   
Send AJMPlus story to a colleague.

* Your Name
* Your E-mail
* Friend's E-mail
Separate multiple addresses with commas.
  Personal Message
* Indicates required fields
Terms and Conditions: You must submit valid e-mail addresses only. Use of e-mail addresses is subject to the terms of SmartBrief's privacy policy.
Here's the story you're sending:
Thrombolytic therapy saves lives
In-hospital all-cause case fatality rate and case fatality rate attributable to pulmonary embolism in unstable patients was lower in those who received thrombolytic therapy. Thrombolytic therapy resulted in a lower case fatality rate than using vena cava filters alone, and the combination resulted in an even lower case fatality rate. Thrombolytic therapy in combination with a vena cava filter in unstable patients with acute pulmonary embolism seems indicated.  American Journal of Medicine, The (5/2012)